Stay updated on AMX0035 in ALS: Phoenix Clinical Trial

Sign up to get notified when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AMX0035 in ALS: Phoenix Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    No significant content or structural changes detected between the two screenshots. Only minor visual adjustments (layout/formatting) appear, with core study details unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T01:18:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T10:23:44.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Version update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.
    Difference
    0.4%
    Check dated 2025-09-28T03:20:11.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other content changes.
    Difference
    0.2%
    Check dated 2025-09-13T17:42:23.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T15:22:55.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and resources related to Sodium Phenylbutyrate and Amyotrophic Lateral Sclerosis, while also changing the facility name and location details.
    Difference
    3%
    Check dated 2025-08-30T12:01:18.000Z thumbnail image

Stay in the know with updates to AMX0035 in ALS: Phoenix Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.